Position in DHR
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,116,593
-$8,303 QoQ
Shares Held
5,862
-1.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#1,060
of 2,098 holders
Holding Since
Mar 2021
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Bridgewater Advisors Inc. holds $2,309,829 across 2 Diagnostics & Research names. DHR ranks #2 (48.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,380 | $1,193,236 | |
| 2 | DHR |
Danaher Corp /De/
This page
|
5,862 | $1,116,593 |
All Filings in DHR
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,116,593 | 5,862 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,124,896 | 5,933 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,447,690 | 6,324 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,247,253 | 6,291 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,234,229 | 6,248 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,308,310 | 6,382 | Shares | Sole | 2025-05-02 | |
| 2022-06-30 | $1,147,431 | 4,526 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $1,352,251 | 4,610 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $1,488,112 | 4,523 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $1,367,544 | 4,492 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $1,202,521 | 4,481 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $992,377 | 4,409 | Shares | Sole | 2021-05-20 | |
| No filing history on record for this holder in this stock. | ||||||